Samsung Bioepis Humira biosimilar wins FDA approval

(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck& Co Inc, which is commercializing the drug in the United States)

Source: Reuters: Health - July 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news